Metastatic Gastric Cancer CME
We provide metastatic gastric cancer CME via online activities and regional live meetings. Expert faculty discuss topics such as development, progression, and targeted therapies for metastatic gastric cancer and gastroesophageal junction adenocarcinoma. Learn the latest research findings and data presented at cancer conferences by participating in an activity below.
Targeted therapies and new approaches to immunotherapy are changing the treatment of metastatic gastric and gastroesophageal (GEJ) cancer. Biomarker testing and rational sequencing are essential for optimal treatment selection and outcomes. To ensure that treatment choices coincide with patient preferences, goals, and expectations, it is essential to involve patients via shared decision making.